AU5587799A - Protein transport-associated molecules - Google Patents
Protein transport-associated moleculesInfo
- Publication number
- AU5587799A AU5587799A AU55877/99A AU5587799A AU5587799A AU 5587799 A AU5587799 A AU 5587799A AU 55877/99 A AU55877/99 A AU 55877/99A AU 5587799 A AU5587799 A AU 5587799A AU 5587799 A AU5587799 A AU 5587799A
- Authority
- AU
- Australia
- Prior art keywords
- protein transport
- associated molecules
- molecules
- protein
- transport
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9820698P | 1998-08-27 | 1998-08-27 | |
US60098206 | 1998-08-27 | ||
PCT/US1999/019616 WO2000012703A2 (en) | 1998-08-27 | 1999-08-26 | Protein transport-associated molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5587799A true AU5587799A (en) | 2000-03-21 |
Family
ID=22267998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55877/99A Abandoned AU5587799A (en) | 1998-08-27 | 1999-08-26 | Protein transport-associated molecules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1108019A2 (en) |
JP (1) | JP2002523089A (en) |
AU (1) | AU5587799A (en) |
CA (1) | CA2340794A1 (en) |
WO (1) | WO2000012703A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192589B2 (en) * | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
JP2004528002A (en) * | 2000-06-29 | 2004-09-16 | インサイト・ゲノミックス・インコーポレイテッド | Secretory and transport molecules |
JP2003259872A (en) * | 2002-03-07 | 2003-09-16 | Japan Science & Technology Corp | Human esophageal carcinoma antigenic peptide and method for diagnosing esophageal carcinoma |
HUE026423T2 (en) | 2005-11-04 | 2016-05-30 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
EP2024391A2 (en) * | 2006-06-01 | 2009-02-18 | Genentech, Inc. | Crystal structure of crig and c3b: crig complex |
US7776573B2 (en) | 2006-06-01 | 2010-08-17 | Genentech, Inc. | Crystal structure of CRIg and C3b:CRIg complex |
MY183804A (en) | 2006-11-02 | 2021-03-16 | Genentech Inc | Humanized anti-factor d antibodies |
AR066660A1 (en) | 2007-05-23 | 2009-09-02 | Genentech Inc | PREVENTION AND TREATMENT OF EYE CONDITIONS ASSOCIATED WITH THEIR COMPLEMENT |
CR20170001A (en) | 2008-04-28 | 2017-08-10 | Genentech Inc | ANTI FACTOR D HUMANIZED ANTIBODIES |
PE20141549A1 (en) | 2008-05-06 | 2014-10-25 | Genentech Inc | MATURE CRIG VARIANTS BY AFFINITY |
KR20160042438A (en) | 2013-08-12 | 2016-04-19 | 제넨테크, 인크. | Compositions and method for treating complement-associated conditions |
TW201623337A (en) | 2014-05-01 | 2016-07-01 | 建南德克公司 | Anti-Factor D antibody variants and uses thereof |
WO2017075173A2 (en) | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibodies and conjugates |
EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
-
1999
- 1999-08-26 CA CA002340794A patent/CA2340794A1/en not_active Abandoned
- 1999-08-26 EP EP99942518A patent/EP1108019A2/en not_active Withdrawn
- 1999-08-26 JP JP2000567690A patent/JP2002523089A/en active Pending
- 1999-08-26 AU AU55877/99A patent/AU5587799A/en not_active Abandoned
- 1999-08-26 WO PCT/US1999/019616 patent/WO2000012703A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002523089A (en) | 2002-07-30 |
WO2000012703A2 (en) | 2000-03-09 |
CA2340794A1 (en) | 2000-03-09 |
EP1108019A2 (en) | 2001-06-20 |
WO2000012703A3 (en) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2434199A (en) | Protein | |
AU2113599A (en) | Human protease molecules | |
AU4922497A (en) | Interleukin-18-receptor proteins | |
AU6721696A (en) | Cd44-like protein | |
AU6045900A (en) | Interaction-activated proteins | |
AU2373800A (en) | Neuron-associated proteins | |
AU5587799A (en) | Protein transport-associated molecules | |
AU2587399A (en) | Human transport-associated molecules | |
AU2113899A (en) | Human protein kinase molecules | |
AU3002199A (en) | Protein phosphatase-related molecules | |
AU6000698A (en) | Proteins | |
AU6275098A (en) | Novel h-rev 107-like protein | |
AU2659600A (en) | Adipose specific protein | |
AU4857999A (en) | Neurotransmission associated proteins | |
AU6410599A (en) | Novel protein phosphatase molecules and uses therefor | |
AU2538899A (en) | Protein kinase c | |
AU6962598A (en) | Thioredoxin-like protein | |
AU1331600A (en) | Growth factor related molecules | |
AU4992099A (en) | Human presenilin-associated protein | |
AU2593199A (en) | Human smn-like protein | |
AU1540701A (en) | Novel protein | |
AUPP460498A0 (en) | Modified proteins | |
AU4438599A (en) | Human arf-related proteins | |
AU5467099A (en) | Novel apoptosis proteins | |
AU2591099A (en) | Human proteinase molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK10 | Application lapsed section 142(4)(b) - petty patent: applicant didn't comply with a notice from commissioner | ||
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |